CytoReason
PrivateLast Round
Debt
Jul 17, 2024
Total Funding Raised
$152M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
CytoReason is a biotechnology company that offers cell-based models and data analysis services to create computational models of the human body for simulating diseases at the cellular level.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoReason Comparables
Compare CytoReason with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aitia | 82% | |
| Insilico Medicine | 82% | |
| Protai | 79% |
CytoReason Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 17, 2024 | ||||
| Strategic | Sep 20, 2022 | ||||
| Series A | Jun 1, 2021 | ||||
| Seed | Jan 1, 2020 |
Key People
Founding team and executive leadership
CytoReason Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pontifax Venture Capital | Seed |
| Pico Venture Partners | Series A, Seed |
| Pfizer | Debt, Strategic |
| Bank Hapoalim | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 613% MoM.
- Jan 15, 2026
Launched new product at the JPM HealthCare Conference 2026.
CytoReason Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CytoReason's valuation, stock price, and market status.
Is CytoReason a public or private company?
CytoReason is a private company.
What is the current stock price of CytoReason?
CytoReason is a private company with no public stock price. No recent secondary market data is available.
How much is CytoReason worth (valuation)?
Valuation information for CytoReason is not publicly available.
Can I buy CytoReason stock?
CytoReason shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CytoReason's last funding round?
CytoReason's most recent funding round was Series C on July 17, 2024.
Who are the main investors in CytoReason?
Key investors in CytoReason include Pfizer.
Will CytoReason IPO soon?
No public IPO plans have been announced for CytoReason.
How can I track CytoReason secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CytoReason's secondary market activity and sign up for updates.